BMY vs HALO
Bristol Myers Squibb vs Halozyme — AI-powered side-by-side comparison
| Metric | BMY | HALO |
|---|---|---|
| AI Score | 61 | 70 |
| Price | $65.46 | $82.25 |
| P/E Ratio | 14.39× | 28.27× |
| ROE | 38.2% | 649.2% |
| Revenue Growth YoY | — | — |
| Gross Margin | 70.2% | 76.9% |
| Debt / Equity | 1.93× | 9.76× |
| Dividend Yield | 3.8% | 0.0% |
| RSI (14) | 79.6 | 65.4 |
| Beta | 0.235 | 0.837 |
| Expected Upside | +1.4% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
HALO Full Analysis